AI Agents for Real-time Med Device Post-Market Surveillance (2026)
Explore how AI agents will revolutionize real-time medical device post-market surveillance by 2026, ensuring proactive compliance with FDA 21 CFR Part 820, ISO 13485, and HIPAA.
Article content
Leveraging AI Agents for Real-time Medical Device Post-Market Surveillance in 2026
Context for MedTech teams
This topic shows up every week in vendor management and perioperative coordination. The short version: make it easy for qualified reps to support cases while maintaining airtight compliance and safety guardrails. Align hospital policy with your credentialing workflow, keep training and immunization evidence current, and close the last‑mile gap between your credentialing system and the OR desk.
If you are rolling out updates across facilities, standardize the “source of truth” for rep status, implement pragmatic exception handling, and partner early with IT and legal on privacy and device security. Those moves reduce day‑of‑surgery friction and help you demonstrate audit‑ready controls.
Further reading
For deeper context on credentialing, OR access, and validation, explore these resources: